Literature DB >> 16557746

Solubilization and Characterization of a Protective Antigen of Erysipelothrix rhusiopathiae.

R R White1, W F Verwey.   

Abstract

A particulate fraction of Erysipelothrix rhusiopathiae cultures has been subjected to butanol extraction and treatment with surface-active agents in an attempt to solubilize a protective antigen. The particulate fraction was partitioned into the butanol layer but was not solubilized. Only sodium dodecyl sulfate solubilized the particles. The soluble protective activity was not sedimented by centrifugation at 198,000 x g for 12 hr but was excluded by Sephadex G-200. Immunodiffusion studies of the soluble fraction demonstrated eight antigens, five of horse serum origin and three of E. rhusiopathiae origin. Ultracentrifugation indicated that spontaneous reaggregation occurred after removal of the sodium dodecyl sulfate. Analytical ultracentrifugation showed that 90% of the sodium dodecyl sulfatetreated material migrated as a single homogeneous 3.5S component. The physical and biological characteristics of the protective activity suggest that the protective antigen is a glyco-lipoprotein.

Entities:  

Year:  1970        PMID: 16557746      PMCID: PMC415910          DOI: 10.1128/iai.1.4.387-393.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  4 in total

1.  Effect of urea on behavior of the protein moiety of human-serum alpha-lipoproteins in solution.

Authors:  S S SANBAR; P ALAUPOVIC
Journal:  Biochim Biophys Acta       Date:  1963-04-02

2.  Localization of enzymes in the microbial cell.

Authors:  M ALEXANDER
Journal:  Bacteriol Rev       Date:  1956-06

3.  Isolation and Characterization of a Protective Antigen-Containing Particle from Culture Supernatant Fluids of Erysipelothrix rhusiopathiae.

Authors:  R R White; W F Verwey
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

4.  Separation and purification of enzymes associated with insoluble particles.

Authors:  R K MORTON
Journal:  Nature       Date:  1950-12-30       Impact factor: 49.962

  4 in total
  8 in total

1.  Truncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigs.

Authors:  Y Imada; N Goji; H Ishikawa; M Kishima; T Sekizaki
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.

Authors:  Fang Shi; Yohsuke Ogawa; Akiyuki Sano; Tomoyuki Harada; Jiro Hirota; Masahiro Eguchi; Eiji Oishi; Yoshihiro Shimoji
Journal:  Infect Immun       Date:  2013-09-09       Impact factor: 3.441

3.  Solubilization and characterization of surface antigenic components of Erysipelothrix rhusiopathiae T28.

Authors:  P G Lachmann; H Deicher
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunity.

Authors:  Y Shimoji; Y Mori; V A Fischetti
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Cloning and expression in Escherichia coli of a protective antigen of Erysipelothrix rhusiopathiae.

Authors:  J E Galán; J F Timoney
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae.

Authors:  M H Groschup; K Cussler; R Weiss; J F Timoney
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

7.  Presence of a capsule in Erysipelothrix rhusiopathiae and its relationship to virulence for mice.

Authors:  Y Shimoji; Y Yokomizo; T Sekizaki; Y Mori; M Kubo
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 8.  Erysipelothrix Spp.: Past, Present, and Future Directions in Vaccine Research.

Authors:  Tanja Opriessnig; Taya Forde; Yoshihiro Shimoji
Journal:  Front Vet Sci       Date:  2020-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.